2018 cohort company Lapovations has hired Spencer Jones as the company’s chief technology officer and vice president of sales and will lead product innovation and the sales and distribution of the company’s flagship product, AbGrab. Learn more here.
2018 cohort company Medical Informatics Corp. has raised $27 million in financing with a $17 million Series B co-led by Catalio Capital Management through Catalio’s venture capital strategy, and Intel Capital. Learn more here.
2018 cohort company Medical Informatics Corp. announced it has signed a reseller agreement with Wilhelm, an Australian-owned integrated healthcare technology company with a mission to improve health in Australia and New Zealand. Wilhelm is now authorized to resell MIC’s FDA-Cleared Sickbay Clinical Platform in Australia and New Zealand. Learn more here.
2019 cohort company OMNY Health announced a $17 million Series B round led by Chicago Pacific Founders (CPF). Dr. Vance Vanier, MD, Co-Founder and Co-Managing Partner of CPF will join the OMNY Board of Directors. Learn more here.
2020 cohort company Zeto announced its partnership with Next Gen Neuro, a continuous and routine EEG monitoring company, to provide remote EEG monitoring services. Learn more here.
2020 cohort company Zeto now offers remote routine or continuous electroencephalography (EEG) monitoring services to its customers. At a fixed hourly rate, an accredited monitoring service provides real-time remote video EEG monitoring by registered EEG technologists (R.EEG.T) when such personnel are unavailable on-site. This service is available in real-time upon request with a 30-minute notice 24/7/365, at no extra charge during nights, weekends, or holidays. Learn more here.
2021 cohort company Genetesis’ founders were featured in this years Forbes 30 Under 30 list in the healthcare category. Learn more here.
2022 cohort company Acorai announced endorsements from two major healthcare players as they prepare the Acorai Heart Monitor for regulatory submission and clinical use within the next 18 months. Learn more here.
2022 cohort company Echo IQ has raised $3.27 million to fund the United States expansion of its artificial intelligence-based medical technology that supports enhanced diagnosis in structural heart disease. Learn more here.